Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PCG vs MRNA✓SelectedUSD · MRNAPCG vs MRNA performance historyLatest closeAs of+1.68%11/19
Stock and ETF performance explorer

PCG vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-19.4%
MRNA return
+159.5%
Excess return
-179.0%
Maximum drawdown
-43.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.7%+1.3%+0.4%+1.7%
7D+7.5%-13.8%+21.3%+7.6%
30D+5.8%-17.7%+23.4%+5.9%
3M-20.7%+14.3%-35.0%-20.9%
6M-14.5%+336.0%-350.4%-17.7%
YTD-12.4%+575.9%-588.3%-18.1%
1Y-10.2%+724.4%-734.5%-17.1%
All-19.4%+159.5%-179.0%-24.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling